Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical 2023-06-21 17:32
Novo Nordisk Global Business Services earns the Best Place To Work certificate in India for 2023 2023-06-21 17:07
Jadeite Medicines Receives Orphan Drug Designation for Odevixibat in Progressive Familial Intrahepatic Cholestasis (PFIC) from the Ministry of Health, Labour and Welfare of Japan and will also initiate Phase 3 Trial of Odevixibat in PFIC in Japan 2023-06-21 09:00
Everest Medicines' Partner Calliditas Therapeutics Makes Data Presentations on Nefecon at European Renal Association - European Dialysis and Transplant Association Congress (ERA-EDTA ) 2023-06-21 08:15
Telix Urology Innovation Showcase to be held at The Yale Club, New York City 2023-06-21 06:31
Clarity commences COMBAT theranostic prostate cancer trial in the US 2023-06-20 21:03
Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at ERS2023 2023-06-20 21:00
Minghui Pharmaceutical Inc. Announces First Patient Dosing in Phase 1 Clinical Studies of Both the Antibody-Drug Conjugate Programs Targeting TROP-2 or B7-H3 Respectively, for Treatment of Advanced or Metastatic Solid Tumors 2023-06-20 18:30
Curocell announced encouraging updates on the next-generation anti-CD19 CAR-T, Anbalcabtagene-autoleucel at International Conference on Malignant Lymphoma (ICML) 2023 2023-06-20 08:01
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development 2023-06-19 21:29
Allgenesis Announces Encouraging Phase 1b Data Showing AG-80308 Providing Improvements in Multiple Signs and Symptoms in Dry Eye Patients 2023-06-19 16:00
Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients 2023-06-19 06:30
The 'Penicillin' of Antivirals, Xafty by Hyundai Bioscience, Opened a New Era of Treating Respiratory Viral Infections with Single Drug 2023-06-18 03:30
The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer 2023-06-16 22:01
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million 2023-06-16 14:20
Everest Medicines Appoints Dr. Mike Berry as Chief Technology Officer 2023-06-16 07:45
Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall 2023-06-16 06:05
Qiming Venture Partners fosters life science, medical and healthcare talent development First healthcare catalyst program starts recruiting in Hong Kong universities 2023-06-15 22:58
Mabwell Announces the U.S. FDA approval of 9MW3811 for IND 2023-06-15 21:00
Mabwell Publishes the Preclinical Study Results on Its Nectin-4 Targeting ADC in A Well-known AACR Journal 2023-06-15 21:00
1 58 59 60 61 62 376